Conferences Protagonist Therapeutics is attending in 2026
Protagonist Therapeutics is listed at 2 conferences on Tnuki's calendar in 2026: BIO-Europe 2026 (on the program) and Discovery on Target 2026 (on the program). Protagonist Therapeutics develops peptide drugs, including oral IL-23 receptor and IL-17 antagonists and the hepcidin mimetic rusfertide. As of Oct 20, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
BIO-Europe 2026European biotech partnering & BDOfficial site |
Cologne, Germany ~5.8k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 workshopAttending EVP, Business Development
|
Open the guide Search and filter attendees |
Discovery on Target 2026Target discovery biologists & chemistsOfficial site |
Past Boston, MA ~1.1k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 roundtable discussion, 1 talk
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Protagonist Therapeutics’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.
Instantly find decision makers at Protagonist Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!